Insider Trading activities of Aquestive Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aquestive Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aquestive Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Aquestive Therapeutics, Inc. since 2005. The reporting company's ticker symbol is AQST. The reporting company's CIK number is 1398733.
The total value of stock buying since 2005 is $2,783,356.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aquestive Therapeutics, Inc. (AQST).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-12 9,000 $77,509 0 $0 0 $0
2018-11 23,095 $230,847 0 $0 29,144 $0
2018-09 0 $0 0 $0 658 $0
2018-08 0 $0 0 $0 29,144 $0
2018-07 165,000 $2,475,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Aquestive Therapeutics, Inc. insiders (AQST)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-12-10 Barber Daniel (SVP-Chief Strategy/Dev Officer) Buy 1,000 8.00 8,000
2018-12-10 Schobel Alexander Mark (Chief Innovation/Tech Officer) Buy 1,000 7.78 7,780
2018-12-06 Maxwell John T. (SVP-Chief Financial Officer) Buy 5,000 8.87 44,349
2018-12-06 Schobel Alexander Mark (Chief Innovation/Tech Officer) Buy 2,000 8.69 17,380
2018-11-30 Schobel Alexander Mark (Chief Innovation/Tech Officer) Option Ex 14,572 .00 0
2018-11-30 Kendall Keith J (CEO and President) Option Ex 14,572 .00 0
2018-11-27 Braender Lori J (General Counsel) Buy 1,000 10.57 10,570
2018-11-27 Kendall Keith J (CEO and President) Buy 1,000 9.87 9,870
2018-11-26 Wood Theresa (SVP-HR and Org. Development) Buy 500 10.34 5,170
2018-11-23 Kendall Keith J (CEO and President) Buy 1,950 9.90 19,305
2018-11-21 Marshall Ken W. (Commercial Leader) Buy 1,445 10.15 14,666
2018-11-21 Boyd Peter E. (SVP-Operations/Value Delivery) Buy 200 9.98 1,996
2018-11-21 Maxwell John T. (SVP-Chief Financial Officer) Buy 10,000 9.80 98,000
2018-11-21 Schobel Alexander Mark (Chief Innovation/Tech Officer) Buy 1,000 10.25 10,250
2018-11-21 Kendall Keith J (CEO and President) Buy 6,000 10.17 61,020
2018-09-30 Schobel Alexander Mark (Chief Innovation/Tech Officer) Option Ex 329 .00 0
2018-09-30 Kendall Keith J (CEO and President) Option Ex 329 .00 0
2018-08-31 Schobel Alexander Mark (Chief Innovation/Tech Officer) Option Ex 14,572 .00 0
2018-08-31 Kendall Keith J (CEO and President) Option Ex 14,572 .00 0
2018-07-24 Bratton Capital Inc. (10% Owner) Buy 165,000 15.00 2,475,000

Insider trading activities including stock purchases, stock sales, and option exercises of AQST listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aquestive Therapeutics, Inc. (symbol AQST, CIK number 1398733) see the Securities and Exchange Commission (SEC) website.